Albany Molecular Research, Inc. focuses on developing biologically active small molecules in the United States, India, and Singapore. It primarily provides chemistry services and proprietary drug discovery technologies used to identify new lead compounds. The company engages in chemistry research from lead discovery, optimization, and development to commercial manufacturing; and conduct cell and noncell-based high throughput screening on various biological targets. The company’s medicinal chemistry services include: design and synthesis of potential lead compounds; design, modify, and synthesis of compounds to improve receptor binding and selectivity, enzyme inhibition, and...